LCP
AVNS

Lombardia Capital Partners’s Avanos Medical AVNS Stock Holding History

Lombardia Capital Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-321,701
Closed -$10.5M – 179
2016
Q2 		$10.5M Sell
321,701
-299,917
-48% -$9.19M 0.69% 57
2016
Q1 		$17.9M Buy
621,618
+40,013
+7% +$1.07M 0.93% 40
2015
Q4 		$19.4M Buy
581,605
+511,463
+729% +$15.9M 0.97% 35
2015
Q3 		$2M Buy
+70,142
New +$2.45M 0.1% 137

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Lombardia Capital Partners's AVNS Position: Q3 2016 in Review

Lombardia Capital Partners sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 321,701 shares — an estimated $10.5M sold.

Lombardia Capital Partners first reported a position in AVNS in Q3 2015 and held it in 4 quarters. The position peaked at $19.4M in Q4 2015. 359 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

  • Lombardia Capital Partners reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
  • Lombardia Capital Partners sold 321,701 Avanos Medical shares in Q3 2016, an estimated $10.5M.
  • Lombardia Capital Partners first reported a position in Avanos Medical in Q3 2015 and held it in 4 quarters.
  • Lombardia Capital Partners's Avanos Medical position peaked at $19.4M in Q4 2015.
  • 359 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Lombardia Capital Partners's 13F filing for Q3 2016, filed 9 Nov 2016.